Enbrel Leukemia Lawyers
Enbrel Can Cause Leukemia. Did you or someone you love develop leukemia while being treated with Enbrel? Enbrel and similar drugs known as TNF (Tumor Necrosis Factor) blockers have been tied to an increased risks of cancer, including leukemia, in children, adolescents, and adults. In 2009, a Boxed Warning was added to the labels of … [Read more...]
Enbrel Side Effects May Be Linked To Autoimmune Disease Lawsuits
Enbrel Side Effects Injury Lawsuit. The FDA approved Enbrel (Generic: Etanercept), which is used to treat Rheumatoid Arthritis, on June 6, 2000. Enbrel is a popular drug used by over 70,000 Rheumatoid Arthritis patients in the United States. On October 17, 2000, Immunex Corp. the manufacturer of Enbrel stated that the drug might … [Read more...]
Amgen Agrees to $71 Million Settlement in Allegations of Unlawful Promotion of Aranesp
Amgen Inc. has agreed to a $71 million settlement with 48 state attorneys general who accused the drug maker of unlawfully marketing its anemia drug Aranesp and plaque psoriasis drug Enbrel, for uses beyond the scope of their Food and Drug Administration's approvals. The Thousand Oaks, California-based drug maker agreed to a … [Read more...]
FDA Releases Humira, Enbrel, Remicade Info
Humira, Enbrel, Remicade Safety Informations. Federal regulators have released more information regarding cancers associated with drugs like Humira, Enbrel, and Remicade. Last month, the Food & Drug Administration (FDA) had mandated that the Black Box Warnings on these drugs - known as TNF blockers - highlight their possible … [Read more...]
Humira, Cimzia, Enbrel and Remicade Infection Warnings
Humira, Cimzia, Enbrel and Remicade Infection Warnings. Federal regulators have ordered the makers of Humira, Cimzia, Enbrel, and Remicade to strengthen the existing warnings about opportunistic fungal infections linked to the drugs. At least 45 people are known to have died from such infections. The Food & Drug … [Read more...]
Despite Enbrel Risks, FDA Panel Recommends it for Psoriasis in Children
FDA Recommends Enbrel for Psoriasis in Children. A Food & Drug Administration (FDA) advisory panel has recommended that the agency approve Enbrel to treat moderate-to-severe psoriasis in children, despite concerns that the drug has been linked to cancer and serious infections, including tuberculosis. Enbrel is already approved … [Read more...]
Enbrel Infection Risk
Enbrel Infection Risk. Enbrel has been linked to sometimes deadly infections when administered to children, casting doubts that the Food & Drug Administration (FDA) will approve the Amgen and Wyeth drug to treat severe psoriasis in children. Enbrel is already approved to treat psoriasis and rheumatoid arthritis in adults and … [Read more...]
Humira, Enbrel, Remicade Cancer Link
Humira, Enbrel, Remicade Are Being Investigated. Humira and other drugs used to treat autoimmune disorders are being investigated by federal regulators amid concern that they might be linked to cancer in children and young people. The drugs are known as tumor necrosis factor (TNF) blockers, and are used to treat various forms of … [Read more...]
Enbrel Tuberculosis Risk
Enbrel Black Box Warning. Enbrel, a drug used to treat psoriasis that has been associated with serious infections, including tuberculosis in some patients. Enbrel's labeling will now carry the Food & Drug Administration's (FDA) strictest safety notice, a black box warning. Enbrel, manufactured by Amgen and Wyeth, is made from … [Read more...]
Enbrel Gets Stronger Infection Warnings
Enbrel Stronger Infection Warnings. Enbrel, a popular treatment for rheumatoid arthritis and psoriasis, is getting stronger warnings about serious infections associated with its use. Yesterday, Amgen and Wyeth added the strongest U.S. Food and Drug Administration (FDA) warning—the “black box”—to the prescribing information Enbrel. … [Read more...]
Enbrel on New Jersey Amgen Probe
New Jersey Amgen Probe. The marketing of Enbrel is the now the subject of an investigation by the New Jersey Attorney General’s Office. The Enbrel probe will look into allegations that Amgen, the maker of the psoriasis drug, instructed Enbrel sales representatives to violate patient confidentiality rules and engage in the illegal … [Read more...]
Enbrel Marketing Scheme Violated HIPAA, Former Amgen Employees Claim
Enbrel Marketing Scheme Violated HIPAA. Two former Amgen employees are charging that the drug maker engaged in illegal marketing practices in an attempt to increase sales of the drug Enbrel. The former Amgen salespeople claim that they were encouraged by the company to illegally access patient records to induce insurance carriers … [Read more...]
